Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 1997

View Archived Issues

Human SMC migration factor and modulators thereof described by SKB and HGS

GnRH conjugate vaccines prepared at Merck & Co.

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

Chiroscience reports PDE/TNF inhibitors

Trovafloxacin extensively covered at recent congress

Efficacy reported for FR-167653 in animal model of septic shock

Nasal vs. rectal midazolam as premedication in children

New emulsion formulation of tacrolimus provides local immunosuppression

JTV-506 shows potential for asthma

Prosorba column trial for rheumatoid arthritis to continue

New protease inhibitor from HMR characterized

Cypros licenses patents for CPC-111 in organ transplant

SAR described for small-molecule ETA antagonists from ImmunoPharmaceutics

FDA approves Niaspan for the treatment of mixed lipid disorders

Research Triangle Institute investigates compounds for male fertility control

Potent and selective AMPA antagonist discovered by Yamanouchi

Device for snoring cleared by FDA

FDA to regulate ultrasound contrast agents as drugs

FDA advisory panel recommends nonapproval of Heart Laser TMR System

Molecular Biosystems' Optison reclassified as drug

New Japanese distribution agreement for Cortecs' H. pylori test

Licenses offered for cell replication technology

Daiichi's new anticancer agent enters overseas clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...